The translational landscape of reactive astrocytes reveals the impact of eIF2B-mediated dysregulation in VWM disease
Year: 2025
Type: article
Abstract: A devastating genetic recessive neurodegenerative disorder, Vanishing White Matter Disease (VWMD), stems from mutations in eIF2B—a master regulator of mRNA translation initiation and mediator of cellular stress response. While astrocytes, the brain’s essential support cells, are known to be central to VWMD pathology, the molecular mechanisms underlying their dysfunction remain poorly understood. Our study reveals that even a mild mutation in eIF2B5 profoundly disrupts astrocyte mRNA translation regulation upon cytokine-mediated activation, affecting nearly one-third of all expressed genes. Through innovative integration of RNA-seq and Ribo-seq analyses using primary cell cultures of astrocytes isolated from eIF2B5 R132H/R132H mice, we discovered attempts to compensate for impaired protein production by increasing mRNA levels. However, this compensation proves insufficient to maintain critical cellular functions. Our comprehensive analysis uncovered significant disruptions in cellular energy production and protein synthesis machinery. We also predicted previously unknown defects in cholesterol biosynthesis within mutant astrocytes. Moreover, a meta-analysis of translation initiation scores pinpointed, for the first time, a short list of specific ’effector’ gene candidates that may drive disease progression. This powerful combination of transcriptome and translatome illuminates the complex pathophysiology of VWMD and identifies promising new biomarkers and therapeutic target opportunities.
Source: NAR Molecular Medicine
Authors: Shir Mandelboum, Liat Lev-Ari, Andrea Atzmon, Melisa Herrero, Naama Brezner, Daniel Benhalevy, Orna Elroy-Stein
Institution: Tel Aviv University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,300
Funder: Israel Science Foundation
Award: G5217086993
OpenAlex ID: W4408907211
